The Rochester-based health system and venture capital firm Eclipse launched RadioPharma in October with $6 million in seed funding. The startup aims to develop technology for cancer-treating radiopharmaceuticals.
“If you’re an individual needing that therapy, it needs to be manufactured for you. … It needs to be available. Because of this problem, we’re now working with investors and third parties to bring manufacturing capability not just to Mayo but to make it available countrywide,” Jim Rogers III, chief business development officer of Mayo Clinic, said at a January press conference, according to the Post Bulletin. “That’s the type of activity that we really focus on. These are the types of collaborations that we think are important.”
A Rochester City Council public hearing on the Minnesota Investment Fund grant application is set for Feb. 6, according to the Jan. 30 story.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
